Board Meeting Details
- Meeting scheduled: Wednesday, October 28, 2026
- Primary agenda: Consider and approve Un-Audited Standalone and Consolidated Financial Results for the Second Quarter ended September 30, 2026
- Additional agenda: Consider and approve Un-Audited Standalone and Consolidated Financial Results for the half year ended September 30, 2026
Trading Window Status
- Trading window closure effective: October 1, 2026
- Applicable to: Designated Persons and their immediate relatives
- Regulatory basis: SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended and the Company's 'Code of conduct'
- Reference to previous communication: Letter dated September 28, 2026
- Trading window reopening: Forty-Eight (48) hours after the declaration of Un-Audited Standalone & Consolidated Financial Results for Q2 and half year ended September 30, 2026
Financial Impact
Financial results not yet declared or quantified in this disclosure. Impact will be determined after board approval on October 28, 2026.